Inolimomab

Modify Date: 2025-08-22 16:02:46

Inolimomab Structure
Inolimomab structure
Common Name Inolimomab
CAS Number 152981-31-2 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula N/A Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Inolimomab


Inolimomab is an anti-interleukin-2 receptor (IL-2R) α chain monoclonal antibody. Inolimomab improves the survival rate of patients in the early research of treating acute graft-versus-host disease (aGVHD)[1][2].

 Names

Name Inolimomab

 Inolimomab Biological Activity

Description Inolimomab is an anti-interleukin-2 receptor (IL-2R) α chain monoclonal antibody. Inolimomab improves the survival rate of patients in the early research of treating acute graft-versus-host disease (aGVHD)[1][2].
Related Catalog
References

[1]. Socié G, et al. A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD. Blood. 2017 Feb 2;129(5):643-649.  

[2]. Piñana JL, et al. Encouraging results with inolimomab (anti-IL-2 receptor) as treatment for refractory acute graft-versus-host disease. Biol Blood Marrow Transplant. 2006 Nov;12(11):1135-41.  

 Chemical & Physical Properties

No Any Chemical & Physical Properties
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.